USPH(USPH)
USPH
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $841M | $899M | $981M |
| Low | $834M | $880M | $968M |
| High | $848M | $915M | $996M |
| EBITDA Avg | $118M | $126M | $138M |
| Low | $117M | $124M | $136M |
| High | $119M | $129M | $140M |
| EBIT Avg | $96M | $103M | $112M |
| Low | $95M | $101M | $111M |
| High | $97M | $105M | $114M |
| Net Income Avg | $44M | $53M | $55M |
| Low | $39M | $48M | $54M |
| High | $45M | $57M | $56M |
| EPS Avg | $2.79 | $3.40 | $3.60 |
| Low | $2.57 | $3.15 | $3.54 |
| High | $2.97 | $3.75 | $3.67 |
| Analysts (Rev / EPS) | 5 / 4 | 6 / 5 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $212M | $218M | $212M | $226M | $226M | $233M |
| Low | $211M | $214M | $209M | $223M | $223M | $230M |
| High | $215M | $221M | $215M | $229M | $230M | $237M |
| EBITDA Avg | $30M | $31M | $30M | $32M | $32M | $33M |
| Low | $30M | $30M | $29M | $31M | $31M | $32M |
| High | $30M | $31M | $30M | $32M | $32M | $33M |
| EBIT Avg | $24M | $25M | $24M | $26M | $26M | $27M |
| Low | $24M | $24M | $24M | $25M | $26M | $26M |
| High | $25M | $25M | $25M | $26M | $26M | $27M |
| Net Income Avg | $12M | $13M | $8M | $14M | $13M | $15M |
| Low | $10M | $12M | $8M | $13M | $13M | $15M |
| High | $13M | $16M | $8M | $14M | $13M | $15M |
| EPS Avg | $0.78 | $0.88 | $0.53 | $0.90 | $0.87 | $1.00 |
| Low | $0.70 | $0.79 | $0.52 | $0.88 | $0.86 | $0.98 |
| High | $0.86 | $1.04 | $0.54 | $0.91 | $0.89 | $1.02 |
| Analysts (Rev / EPS) | 5 / 5 | 7 / 7 | 3 / 2 | 3 / 2 | 3 / 2 | 6 / 5 |